Incretin Mimetic Can Cause Severe, Disabling Joint Pain, FDA Warns
SILVER SPRING, Md. — Incretin mimetic diabetes drug Januvia, Onglyza and Tradjenta can cause severe and disabling joint pain, the Food and Drug Administration warned Aug. 28....To view the full article, register now.
Already a subscriber? Click here to view full article